Prognostic Significance of HIF-1α Expression in Hepatocellular Carcinoma: A Meta-Analysis

Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 6; p. e65753
Main Authors Zheng, Su-Su, Chen, Xiao-Hong, Yin, Xin, Zhang, Bo-Heng
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 14.06.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out. Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate. The combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)]. HIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.
AbstractList AIM: Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out. METHODS: Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate. RESULT: The combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)]. CONCLUSION: HIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.
Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out.AIMPilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out.Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate.METHODSSystematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate.The combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)].RESULTThe combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)].HIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.CONCLUSIONHIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.
Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out. Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate. The combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)]. HIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.
Aim Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1α to predict the prognosis of patients with HCC, a meta-analysis was carried out. Methods Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1α level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1α expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate. Result The combined data suggested that HIF-1α overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1α expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)]. Conclusion HIF-1α overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.
Author Zhang, Bo-Heng
Zheng, Su-Su
Chen, Xiao-Hong
Yin, Xin
AuthorAffiliation 2 Center for Evidence Based Medicine, Fudan University, Shanghai, People’s Republic of China
1 Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China
University of North Carolina School of Medicine, United States of America
AuthorAffiliation_xml – name: 1 Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China
– name: 2 Center for Evidence Based Medicine, Fudan University, Shanghai, People’s Republic of China
– name: University of North Carolina School of Medicine, United States of America
Author_xml – sequence: 1
  givenname: Su-Su
  surname: Zheng
  fullname: Zheng, Su-Su
– sequence: 2
  givenname: Xiao-Hong
  surname: Chen
  fullname: Chen, Xiao-Hong
– sequence: 3
  givenname: Xin
  surname: Yin
  fullname: Yin, Xin
– sequence: 4
  givenname: Bo-Heng
  surname: Zhang
  fullname: Zhang, Bo-Heng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23799043$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustu1DAUjVARfcAfIIjEhk0GO37FXSCNRi0zUhFIwIaNdePYg0cZe7ATRD-LH-Gb8DBp1VaIla3rc8499_ieFkc-eFMUzzGaYSLwm00Yo4d-tsvlGUKcCUYeFSdYkrriNSJHd-7HxWlKG4QYaTh_UhzXREiJKDkpvn6MYe1DGpwuP7m1d9Zp8NqUwZbL1WWFf_8qL37uoknJBV86Xy7NDoagTd-PPcRyAVE7H7ZwXs7L92aAap5dXSeXnhaPLfTJPJvOs-LL5cXnxbK6-vButZhfVZrVfKgIkFYIScGy2gKmnElhBGe0xYzKBoAQ1tiWES06LhrUGUERQS1Y3RotBTkrXh50d31IaoolKUx4w2tGG5oRqwOiC7BRu-i2EK9VAKf-FkJcK4g5gd4oy2ktNcIdti0lKCfILUjTWIRkzQ3JWm-nbmO7NZ02fojQ3xO9_-LdN7UOP1S2QxBHWeD1JBDD99GkQW1d2scJ3oRx71vUXDKKmwx99QD67-le3HV0a-XmkzOAHgA6hpSisbcQjPbt8I2s2u-SmnYp084f0LQbYMhrkOdy_f_JfwCXB9KG
CitedBy_id crossref_primary_10_1242_jcs_141069
crossref_primary_10_1016_j_trecan_2016_10_016
crossref_primary_10_1016_j_phrs_2018_10_009
crossref_primary_10_3892_ijo_2015_2965
crossref_primary_10_1038_s41598_020_70865_7
crossref_primary_10_3389_fonc_2024_1520306
crossref_primary_10_3390_cancers16233959
crossref_primary_10_1016_j_cellsig_2014_03_016
crossref_primary_10_1136_gutjnl_2016_313264
crossref_primary_10_1002_advs_201902040
crossref_primary_10_1093_carcin_bgy190
crossref_primary_10_3389_fonc_2018_00224
crossref_primary_10_1007_s00109_016_1408_1
crossref_primary_10_1016_j_dld_2023_09_019
crossref_primary_10_1016_j_jhepr_2023_100846
crossref_primary_10_5306_wjco_v10_i3_149
crossref_primary_10_3390_medicina59061115
crossref_primary_10_1016_j_xcrm_2021_100444
crossref_primary_10_3724_abbs_2023231
crossref_primary_10_1038_s41392_023_01460_1
crossref_primary_10_3390_cancers15133434
crossref_primary_10_1016_j_critrevonc_2022_103750
crossref_primary_10_1111_jcmm_70241
crossref_primary_10_1111_cas_14941
crossref_primary_10_1155_2022_5424411
crossref_primary_10_1016_j_biopha_2014_11_005
crossref_primary_10_1016_j_cca_2013_10_018
crossref_primary_10_32604_oncologie_2022_023248
crossref_primary_10_1097_MD_0000000000023369
crossref_primary_10_3390_ijms20061503
crossref_primary_10_1007_s12072_020_10104_3
crossref_primary_10_3892_mmr_2014_2574
crossref_primary_10_1038_s41598_020_58124_1
crossref_primary_10_18632_oncotarget_7406
crossref_primary_10_3892_ol_2024_14737
crossref_primary_10_1155_2014_409272
crossref_primary_10_3390_cells9092081
crossref_primary_10_3390_ijms20092347
crossref_primary_10_1007_s13277_013_1579_0
crossref_primary_10_1186_s13018_019_1101_5
crossref_primary_10_1016_j_pmu_2014_03_006
crossref_primary_10_1371_journal_pone_0113591
crossref_primary_10_18632_oncotarget_22078
crossref_primary_10_1155_2019_3769879
crossref_primary_10_1007_s10585_023_10224_8
crossref_primary_10_1136_gutjnl_2019_319616
crossref_primary_10_3390_ph11040094
crossref_primary_10_1007_s40675_017_0062_7
crossref_primary_10_1039_D0TB01295E
crossref_primary_10_26442_18151434_2022_4_202018
crossref_primary_10_54817_IC_v63n1a01
crossref_primary_10_1016_j_jhep_2014_08_025
crossref_primary_10_1007_s10238_020_00667_8
crossref_primary_10_1016_j_semcancer_2022_08_001
crossref_primary_10_18632_oncotarget_7935
crossref_primary_10_1007_s12029_020_00389_w
crossref_primary_10_1080_14737159_2022_2157719
crossref_primary_10_1242_dmm_044768
crossref_primary_10_1007_s10238_024_01521_x
crossref_primary_10_3390_reports3040030
crossref_primary_10_1124_mol_113_089623
crossref_primary_10_3892_ijo_2014_2563
crossref_primary_10_1038_cddis_2015_57
crossref_primary_10_1371_journal_pone_0091842
crossref_primary_10_1002_jmri_28694
crossref_primary_10_1007_s12094_020_02332_8
crossref_primary_10_3390_ijms23052702
crossref_primary_10_1038_srep11846
Cites_doi 10.1097/00000658-200007000-00003
10.1093/carcin/bgs249
10.1007/s11033-011-0949-1
10.1007/s11033-011-0839-6
10.1097/00000658-199903000-00004
10.1002/ijc.26301
10.3748/wjg.v11.i11.1705
10.1007/s10620-008-0296-9
10.1016/S0168-8278(02)00360-4
10.1007/BF03260065
10.1016/j.ejca.2004.04.035
10.1111/j.1478-3231.2006.01243.x
10.3816/CCC.2006.n.005
10.1158/1078-0432.CCR-09-2610
10.1038/nrc704
10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
10.1186/1471-2407-9-418
10.1136/bmj.315.7109.629
10.1038/nrc2540
10.1016/0197-2456(86)90046-2
ContentType Journal Article
Copyright 2013 Zheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2013 Zheng et al 2013 Zheng et al
Copyright_xml – notice: 2013 Zheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2013 Zheng et al 2013 Zheng et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0065753
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Agricultural Science Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
Biology
DocumentTitleAlternate Meta Analysis: HIF-1α in HCC
EISSN 1932-6203
ExternalDocumentID 1368625484
oai_doaj_org_article_f6429c01d1fb4301936fa9e8f00926e3
PMC3683060
2998139041
23799043
10_1371_journal_pone_0065753
Genre Meta-Analysis
Journal Article
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
NPM
PV9
RZL
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c526t-3a3b7794af52fa146597e7654b15498aa3358fb53c7d6780de74030bafcbec973
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Feb 05 03:13:54 EST 2023
Wed Aug 27 01:26:46 EDT 2025
Thu Aug 21 18:20:22 EDT 2025
Fri Jul 11 11:50:00 EDT 2025
Fri Jul 25 10:31:54 EDT 2025
Thu Apr 03 06:59:54 EDT 2025
Tue Jul 01 00:41:53 EDT 2025
Thu Apr 24 22:50:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c526t-3a3b7794af52fa146597e7654b15498aa3358fb53c7d6780de74030bafcbec973
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: B-HZ. Analyzed the data: S-SZ. Wrote the paper: S-SZ X-HC. Independently screened the full text of selected studies to confirm eligibility, assess quality, and extract data: S-SZ X-HC XY.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0065753
PMID 23799043
PQID 1368625484
PQPubID 1436336
ParticipantIDs plos_journals_1368625484
doaj_primary_oai_doaj_org_article_f6429c01d1fb4301936fa9e8f00926e3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3683060
proquest_miscellaneous_1372695418
proquest_journals_1368625484
pubmed_primary_23799043
crossref_primary_10_1371_journal_pone_0065753
crossref_citationtrail_10_1371_journal_pone_0065753
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-06-14
PublicationDateYYYYMMDD 2013-06-14
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-14
  day: 14
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2013
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References XG Lu (ref6) 2006; 5
L Liu (ref8) 2010; 16
CH Zhang (ref15) 2012; 130
R DerSimonian (ref18) 1986; 7
MK Parmar (ref16) 1998; 17
N Mantel (ref19) 1959; 22
H Wada (ref11) 2006; 26
H Imamura (ref22) 2003; 38
R Tung-Ping Poon (ref2) 2000; 232
AL Harris (ref4) 2002; 2
GW Huang (ref9) 2005; 11
JA Bertout (ref21) 2008; 8
S Kimura (ref5) 2004; 40
H Xie (ref14) 2008; 53
C Mao (ref17) 2012; 39
CX Dai (ref12) 2009; 9
L Xia (ref10) 2012; 33
ZL Xiang (ref13) 2012; 39
M Egger (ref20) 1997; 315
J Filmus (ref3) 2004; 8
ST Fan (ref1) 1999; 229
ZZ Dong (ref7) 2010; 18
13655060 - J Natl Cancer Inst. 1959 Apr;22(4):719-48
21647551 - Mol Biol Rep. 2012 Feb;39(2):2021-9
21780114 - Int J Cancer. 2012 Jun 1;130(11):2685-92
20460486 - Clin Cancer Res. 2010 May 15;16(10):2740-50
9921604 - Stat Med. 1998 Dec 30;17(24):2815-34
18465238 - Dig Dis Sci. 2008 Dec;53(12):3225-33
9310563 - BMJ. 1997 Sep 13;315(7109):629-34
15887976 - Mol Diagn. 2004;8(4):207-12
16512994 - Clin Colorectal Cancer. 2006 Jan;5(5):350-3
18987634 - Nat Rev Cancer. 2008 Dec;8(12):967-75
22831955 - Carcinogenesis. 2012 Nov;33(11):2250-9
3802833 - Control Clin Trials. 1986 Sep;7(3):177-88
21603857 - Mol Biol Rep. 2012 Feb;39(2):1113-8
10862190 - Ann Surg. 2000 Jul;232(1):10-24
15288294 - Eur J Cancer. 2004 Aug;40(12):1904-12
11902584 - Nat Rev Cancer. 2002 Jan;2(1):38-47
16629644 - Liver Int. 2006 May;26(4):414-23
12547409 - J Hepatol. 2003 Feb;38(2):200-7
19948069 - BMC Cancer. 2009;9:418
20678440 - Zhonghua Gan Zang Bing Za Zhi. 2010 Jul;18(7):506-10
10077043 - Ann Surg. 1999 Mar;229(3):322-30
15786555 - World J Gastroenterol. 2005 Mar 21;11(11):1705-8
References_xml – volume: 232
  start-page: 10
  year: 2000
  ident: ref2
  article-title: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
  publication-title: Ann Surg
  doi: 10.1097/00000658-200007000-00003
– volume: 33
  start-page: 2250
  year: 2012
  ident: ref10
  article-title: The TNF-alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs249
– volume: 39
  start-page: 2021
  year: 2012
  ident: ref13
  article-title: The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-011-0949-1
– volume: 39
  start-page: 1113
  year: 2012
  ident: ref17
  article-title: Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-011-0839-6
– volume: 229
  start-page: 322
  year: 1999
  ident: ref1
  article-title: Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths
  publication-title: Ann Surg
  doi: 10.1097/00000658-199903000-00004
– volume: 130
  start-page: 2685
  year: 2012
  ident: ref15
  article-title: Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis
  publication-title: Int J Cancer
  doi: 10.1002/ijc.26301
– volume: 11
  start-page: 1705
  year: 2005
  ident: ref9
  article-title: Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v11.i11.1705
– volume: 53
  start-page: 3225
  year: 2008
  ident: ref14
  article-title: The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients’ prognosis and hepatitis B virus X protein
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-008-0296-9
– volume: 22
  start-page: 719
  year: 1959
  ident: ref19
  article-title: Statistical aspects of the analysis of data from retrospective studies of disease
  publication-title: J Natl Cancer Inst
– volume: 18
  start-page: 506
  year: 2010
  ident: ref7
  article-title: [Expression characteristics of hypoxia inducible factor-1a and its clinical values in hepatocellular carcinoma]
  publication-title: Zhonghua Gan Zang Bing Za Zhi
– volume: 38
  start-page: 200
  year: 2003
  ident: ref22
  article-title: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00360-4
– volume: 8
  start-page: 207
  year: 2004
  ident: ref3
  article-title: Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma
  publication-title: Mol Diagn
  doi: 10.1007/BF03260065
– volume: 40
  start-page: 1904
  year: 2004
  ident: ref5
  article-title: Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2004.04.035
– volume: 26
  start-page: 414
  year: 2006
  ident: ref11
  article-title: Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2006.01243.x
– volume: 5
  start-page: 350
  year: 2006
  ident: ref6
  article-title: Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma
  publication-title: Clin Colorectal Cancer
  doi: 10.3816/CCC.2006.n.005
– volume: 16
  start-page: 2740
  year: 2010
  ident: ref8
  article-title: Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-09-2610
– volume: 2
  start-page: 38
  year: 2002
  ident: ref4
  article-title: Hypoxia–a key regulatory factor in tumour growth
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc704
– volume: 17
  start-page: 2815
  year: 1998
  ident: ref16
  article-title: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
– volume: 9
  start-page: 418
  year: 2009
  ident: ref12
  article-title: Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-418
– volume: 315
  start-page: 629
  year: 1997
  ident: ref20
  article-title: Bias in meta-analysis detected by a simple, graphical test
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 8
  start-page: 967
  year: 2008
  ident: ref21
  article-title: The impact of O2 availability on human cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2540
– volume: 7
  start-page: 177
  year: 1986
  ident: ref18
  article-title: Meta-analysis in clinical trials
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– reference: 3802833 - Control Clin Trials. 1986 Sep;7(3):177-88
– reference: 20678440 - Zhonghua Gan Zang Bing Za Zhi. 2010 Jul;18(7):506-10
– reference: 18987634 - Nat Rev Cancer. 2008 Dec;8(12):967-75
– reference: 22831955 - Carcinogenesis. 2012 Nov;33(11):2250-9
– reference: 18465238 - Dig Dis Sci. 2008 Dec;53(12):3225-33
– reference: 21647551 - Mol Biol Rep. 2012 Feb;39(2):2021-9
– reference: 10862190 - Ann Surg. 2000 Jul;232(1):10-24
– reference: 13655060 - J Natl Cancer Inst. 1959 Apr;22(4):719-48
– reference: 15887976 - Mol Diagn. 2004;8(4):207-12
– reference: 20460486 - Clin Cancer Res. 2010 May 15;16(10):2740-50
– reference: 9310563 - BMJ. 1997 Sep 13;315(7109):629-34
– reference: 15288294 - Eur J Cancer. 2004 Aug;40(12):1904-12
– reference: 10077043 - Ann Surg. 1999 Mar;229(3):322-30
– reference: 21780114 - Int J Cancer. 2012 Jun 1;130(11):2685-92
– reference: 11902584 - Nat Rev Cancer. 2002 Jan;2(1):38-47
– reference: 19948069 - BMC Cancer. 2009;9:418
– reference: 21603857 - Mol Biol Rep. 2012 Feb;39(2):1113-8
– reference: 12547409 - J Hepatol. 2003 Feb;38(2):200-7
– reference: 16512994 - Clin Colorectal Cancer. 2006 Jan;5(5):350-3
– reference: 15786555 - World J Gastroenterol. 2005 Mar 21;11(11):1705-8
– reference: 16629644 - Liver Int. 2006 May;26(4):414-23
– reference: 9921604 - Stat Med. 1998 Dec 30;17(24):2815-34
SSID ssj0053866
Score 2.4062924
SecondaryResourceType review_article
Snippet Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma (HCC)...
Aim Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma...
AIM: Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma...
Aim Pilot studies have evaluated the correlation between hypoxia-inducible factor-1α (HIF-1α) overexpression and clinical outcome in hepatocellular carcinoma...
SourceID plos
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e65753
SubjectTerms Biology
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - pathology
Clinical trials
Confidence intervals
Correlation analysis
Disease-Free Survival
Gene Expression
Hepatitis
Hepatocellular carcinoma
Hospitals
Humans
Hypoxia
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Hypoxia-inducible factors
Literature reviews
Liver cancer
Liver Neoplasms - metabolism
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Medical ethics
Medical prognosis
Medicine
Meta-analysis
Metastases
Metastasis
Patients
Prognosis
Studies
Survival
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwELYqTr1U0JYSSitX6oEeDPF_0ltbdbWtVMShSIhLZDu2QIIEsUHqa_VFeCZmEu-KrZC49BbZjhzPj2fGGX9DyMcYvLAiapZsNExFLpkDs8CCiEZbK9vS4XnHryMzP1E_T_Xpg1JfmBM2wQNPhDtM4CDXoeQtT16BNNbSJFfHKiFakIkjzifYvGUwNe3BoMXG5Ity0vLDzJeD676LmMkFPopcM0QjXj_im172i8d8zX9TJh_YoNkmeZGdR_pl-ugt8ix2L8lWVs8F3c8Y0p9ekbPjmx5T6GAgxRQNTAhC_tI-0fmPGeN3f2n8k5NgO3rR0XOwS0OP5_iYmEoD1hjq-iv3mTp6FQfHXIYveU1OZt9_f5uzXEaBBS3MwKST3oLauaRFcrAzQgwRrdHKIzxb5ZyUukpey2BbMF1lG60C1fcuBWBwbeU22eiAcDuEcmhSvm5Tq4wy8BiD8OCAlLzyoXZ1QeSSpk3IGONY6uKyGX-cWYg1Jko1yIkmc6IgbPXW9YSx8cT4r8iu1VhEyB4bQG6aLDfNU3JTkB1k9nKCBUyHl2UggFMF2VsKwOPdH1bdoIvIGNfF_hbHWGFqrXhVkDeTvKw-UkgLhl_BvHZNktZWsd7TXZyPeN8wMwR25e7_WPZb8lxMBT0YV3tkY7i5je_ArRr8-1GD7gEgZiL5
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwELagXLigtvx021IZiQMcTOPYsRMuqFRdLUhFSFBpxSWyHbusVJLtbirxWrwIz8RM4gQWVXCLYidO_Hn-nMk3hDz3zqY69RkL2ismPRfMgFlgLvUq01pUicH9jvMPanYh38-zedxwW8e0ykEndoq6ahzukR9zgf8ygH8t3yyvGVaNwq-rsYTGXXIPqcswpUvPx4ALZFmp-Luc0Pw4ovNq2dQe87nAUxEb5qhj7UeW06tmfZvH-Xfi5B-WaLpNHkQXkp70mO-QO77eJTtRSNf0RWSSfvmQfPm4ajCRDjrST4vLGtOCEGXaBDp7N2X85w969j2mwtZ0UdMZWKe2wd18TE-lp1hpqG6-mdf0hJ771rCBxOQRuZiefT6dsVhMgbksVS0TRlgNwmdClgYD-hEiCa9VJi2StOXGCJHlwWbC6QoMWFJ5LUEBWBMcwFxo8Zhs1TBxe4RyOCVtUYVKKqng0LvUghuS8Ny6whQTIoY5LV1kGseCF1dl9_lMQ8TRz1SJSJQRiQlh41XLnmnjP_3fIlxjX-TJ7k40q8syil0ZILwqXMIrHqwEXVYIFUzh84BcU8rDTfYQ7GGAdfl7mU3I4bAAbm9-NjaDRCIwpvbNDfbRqSoyyfMJedKvl_EhU6HB_EsYV2-spI232GypF1871m8YGcK7ZP_fj3VA7qd9wQ7G5SHZalc3_im4Ta096mTjF452Gk4
  priority: 102
  providerName: ProQuest
Title Prognostic Significance of HIF-1α Expression in Hepatocellular Carcinoma: A Meta-Analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/23799043
https://www.proquest.com/docview/1368625484
https://www.proquest.com/docview/1372695418
https://pubmed.ncbi.nlm.nih.gov/PMC3683060
https://doaj.org/article/f6429c01d1fb4301936fa9e8f00926e3
http://dx.doi.org/10.1371/journal.pone.0065753
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED_tj0C8IFZgC4zKSDzAg6cmduwECaGtailInSagUsVL5CT2qFSS0XbS9rH4Inwm7vKnoqgIiZcoin1xYt_57uzz7wBe2CwNdGBD7rRVXFpfcINqgWeBVaHWIu8ZWu8Yn6vRRH6YhtMdaHO2Nh243OraUT6pyWJ-cvP99i0K_Jsqa4P2W6KTq7KwFKeFFojYhX3UTZpEdSzX-woo3Uo1B-j-RknwwELjJC3Fhq6qIP0JAnVeLreZo39GVf6mpoYP4H5jX7LTmiEOYMcWHbhTZ5y87cDdcbOX3oGDRqyX7GWDPf3qIXy5WJQUeofU7NPssqBAIuILVjo2ej_k_s8fbHDTBM8WbFawEeqzVUnr_xTQyvqUm6gov5nX7JSN7crwFvbkEUyGg8_9EW_SL_AsDNSKCyNSjeJqXBg4gzMq-h5Wq1CmBOsWGSNEGLk0FJnOUeX1cqslThmpcRkyRqzFY9grsGOPgPn4SKZx7nKppMJbmwUpGi49P0qz2MQeiLajk6zBJqcUGfOk2nDT6KPU3ZfQSCXNSHnA11RXNTbHP-qf0Riu6xKydvWgXFwmjaAmDh2yOOv5ue9SibNfLJQzsY0coVMpiy85Ig5oG1hic3TIBh0_6cFxyxXbi5-vi1GGaWBMYctrqqMDFYfSjzw4rJlo_ZEtL3qgN9hr4y82S4rZ1wonHFtGh7D35L8pn8K9oM7-wX15DHurxbV9hjbYKu3Crp5qvEZ9n67Dd13YPxucX3zsVqsa3UrsfgGiWDi3
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAFUV5dWsBIIMHBNLEdO0FCqJSusrRbIdFKq16Ck9hlpTZZdlMBfwqJP8JvYiYvWFTBqbcodmLH847H3xDyxGYp19wGzGmrmLS-YAbMAsu4VYHWIvcM_u8YH6j4SL6bBJMV8r07C4NplZ1OrBV1Xmb4j3zLF3iWAfxr-Xr2mWHVKNxd7UpoNGyxZ799gZBt8Wr0Fuj7lPPh7uFOzNqqAiwLuKqYMCLVwIXGBdwZUBTgUlutApkiWllojBBB6NJAZDoHTe7lVkuQhNS4DL430gLee4VcBcProUTpSR_gge5Qqj2eJ7S_1XLDi1lZWMwfA89ILJm_ukoAoqqelouLPNy_EzX_sHzDm-RG67LS7YbH1siKLW6RtVYpLOizFrn6-W1y_H5eYuIedKQfpicFpiEhV9HS0Xg0ZP7PH3T3a5t6W9BpQWOwhlWJuweYDkt3sLJRUZ6Zl3Sbjm1lWAeacoccXcoy3yWrBSzcOqE-3JJplLtcKqng0mY8BbfH88M0i0w0IKJb0yRrkc2xwMZpUm_XaYhwmpVKkBJJS4kBYf1TswbZ4z_93yC5-r6Iy13fKOcnSSvmiYNwLso8P_ddKkF3RkI5E9nQIbaVsvCSdSR2N8Ai-c3WA7LZMcDFzY_7ZtAASBhT2PIc-2iuokD64YDca_ilnyQXGtwNCePqJU5a-orllmL6qUYZh5EhnPTu_3taj8i1-HC8n-yPDvY2yHXeFAthvtwkq9X83D4Al61KH9ZyQsnHyxbMX0R9VrE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkBAviPFvZQOMBBI8mMZ_YjdICI1tVcvYNAkmVXsJTmKPSltS2k7Ax-KVD8Fn4i5xCkUTPO2tit048f3ufBeff0fIE5dnwggXM2-cZspxySwsCywXTsfGyCKy-L1j_0APjtTbUTxaIT_aszCYVtnaxNpQF1WO38i7XOJZBvCvVdeHtIjDnf7ryWeGFaRwp7Utp9FAZM99-wLh2-zVcAdk_VSI_u6H7QELFQZYHgs9Z9LKzAAirY-Ft2A0wL12RscqQ-aynrVSxj2fxTI3BVj1qHBGgVZk1ufw7omRcN8r5KqRMUcdM6NFsAd2ROtwVE8a3g3IeDGpSoe5ZOAlyaWlsK4YgAyrp9XsIm_376TNP1bB_k1yI7ivdKvB2xpZceUtshYMxIw-CyzWz2-T48NphUl80JG-H5-UmJKECKOVp4Nhn_Gf3-nu15CGW9JxSQewMs4r3EnA1Fi6jVWOyurMvqRbdN_NLWsJVO6Qo0uZ5rtktYSJWyeUwyWVJYUvlFYafrpcZOACRbyX5YlNOkS2c5rmgeUci22cpvXWnYFop5mpFCWRBkl0CFv8a9KwfPyn_xsU16IvcnTXF6rpSRpUPvUQ2iV5xAvuMwV2NJHa28T1PPJcaQc3WUdhtwPM0t8Q75DNFgAXNz9eNIM1QMHY0lXn2McIncSK9zrkXoOXxUMKacD1UDCuWULS0lsst5TjTzXjOIwMoWV0_9-P9YhcA5VM3w0P9jbIddHUDWFcbZLV-fTcPQDvbZ49rNWEko-XrZe_AA66Wuc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Significance+of+HIF-1%CE%B1+Expression+in+Hepatocellular+Carcinoma%3A+A+Meta-Analysis&rft.jtitle=PloS+one&rft.au=Zheng%2C+Su-Su&rft.au=Chen%2C+Xiao-Hong&rft.au=Yin%2C+Xin&rft.au=Zhang%2C+Bo-Heng&rft.date=2013-06-14&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=8&rft.issue=6&rft_id=info:doi/10.1371%2Fjournal.pone.0065753&rft_id=info%3Apmid%2F23799043&rft.externalDocID=PMC3683060
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon